Sinovac Biotech
Chinese biopharmaceutical company / From Wikipedia, the free encyclopedia
Dear Wikiwand AI, let's keep it short by simply answering these key questions:
Can you list the top facts and stats about Sinovac Biotech?
Summarize this article for a 10 year old
SHOW ALL QUESTIONS
This article is about the pharmaceutical company. For the COVID-19 vaccine that it developed, see CoronaVac.
"Sinovac" redirects here. Not to be confused with Sinopharm (company).
40.031°N 116.3003°E / 40.031; 116.3003
Quick Facts Company type, Traded as ...
Company type | Public | ||||||
---|---|---|---|---|---|---|---|
Nasdaq: SVA | |||||||
Founded | 1999; 25 years ago (1999) | ||||||
Founder | Yin Weidong[1] | ||||||
Headquarters | 39 Shang Di West Road, Haidian District, , China | ||||||
Number of employees | 4,281 (as of 2022)[2] | ||||||
Chinese name | |||||||
Simplified Chinese | 科兴控股生物技术有限公司 | ||||||
Traditional Chinese | 科興控股生物技術有限公司 | ||||||
Literal meaning | Kexing Holdings Biotechnology Co., Ltd. | ||||||
| |||||||
Website | www |
Close
Sinovac Biotech Ltd. (Chinese: 科兴控股生物技术有限公司) is a Chinese biopharmaceutical company based in Haidian District, Beijing that focuses on the research, development, manufacture, and commercialization of vaccines that protect against human infectious diseases. The company was listed on the Nasdaq but the exchange halted Sinovac's trading in February 2019 due to a proxy fight.[3][4] The company has faced bribery probes in China.[3]